Bharat Biotech’s biovet secures CDSCO approval for lumpy skin disease vaccine
Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes. Developed using the LSD virus strain from ICAR-NRCE, the vaccine distinguishes between infected and vaccinated animals, enhancing disease surveillance and supporting India's goal for a disease-free livestock population.
Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes. Developed using the LSD virus strain from ICAR-NRCE, the vaccine distinguishes between infected and vaccinated animals, enhancing disease surveillance and supporting India's goal for a disease-free livestock population.
